Skip Navigation



NDT Advance Access published online on September 6, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl341
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/11/3055    most recent
gfl341v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Carlini, R. G.
Right arrow Articles by Weisinger, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlini, R. G.
Right arrow Articles by Weisinger, J. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received March 5, 2006
Accepted May 17, 2006

Original Article

Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro

Raul G. Carlini 1 *, Evelyn Alonzo 1, Ezequiel Bellorin-Font 1, and José R. Weisinger 1

1 Division of Nephrology, Hospital Universitario de Caracas, Universidad Central de Venezuela and Centro Nacional de Diálisis y Trasplante, Caracas, Venezuela

* To whom correspondence should be addressed.
Raul G. Carlini, E-mail: rcarlini{at}cantv.net



  Abstract

Background. Iron sucrose (Fe-S) and low-molecular-weight iron dextran (Fe-D) have been used successfully in the treatment of anaemia in chronic kidney disease patients. However, some side effects, such as endothelial cell dysfunction have been reported. Mechanisms by which iron can induce endothelial cell damage have not been completely understood. This study was designed to examine the effect of Fe-S and Fe-D on bovine aortic endothelial cells in vitro.

Methods. Cell proliferation was determined by [3H] thymidine incorporation, cytotoxicity by lactate dehydrogenase, pro-Caspase-3 by immunoblotting; and Caspase-3 activity using a colorimetric assay. Expression of the apoptosis stress pathway proteins Bcl-2 and Bax and cycle arrest proteins p53 and p21WAF/CIP1 were examined by immunoblot. Cell apoptosis was tested by terminal deoxynucleotidyltransferase-mediated nick-end labelling (TUNEL) and DNA fragmentation.

Results. Both iron preparations inhibited cell proliferation. This effect was more important and occurred at lower concentrations in Fe-S than Fe-D cultured cells. Expression of p53 and p21WAF/CIP1 increased in cells incubated with Fe-S, but not with Fe-D. Bcl-2 expression was significantly down-regulated in cells incubated with Fe-S in comparison with Fe-D, while Bax expression was not modified by the iron compounds. Pro-Caspase-3 expression and Caspase-3 activity increased only in cells treated with Fe-S. Apoptosis was present in cells treated with Fe-S.

Conclusions. Our results demonstrate that Fe-S exerts a greater inhibitory effect on endothelial cell proliferation than Fe-D. The mechanisms involved in this process may be related, at least in part, to over expression of proteins related to the cell cycle arrest and apoptosis stress pathway.

Keywords: apoptosis; endothelial cells; intracellular signal; iron.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
H. Berradi, J.-M. Bertho, N. Dudoignon, A. Mazur, L. Grandcolas, C. Baudelin, S. Grison, P. Voisin, P. Gourmelon, and I. Dublineau
Renal Anemia Induced by Chronic Ingestion of Depleted Uranium in Rats
Toxicol. Sci., June 1, 2008; 103(2): 397 - 408.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. H. Horl
Clinical Aspects of Iron Use in the Anemia of Kidney Disease
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 382 - 393.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.